Weekly Digest – May 2025 Weekly Digest – May 2025 20 May 2025: Antengene enters into a global clinical collaboration with MSD to evaluate ATG-022 (CLDN18.2 ADC) in combination with KEYTRUDA (Pembrolizumab) Antengene has entered a global clinical collaboration with […]